An insurer backs off from new barriers to colonoscopies, but imposes new incenti...
Algorithms that adjust for race raise the threshold for diagnosing a problem in ...
Why are fake medical devices more lucrative than real ones? Is Ozempic a neurolo...
In the latest edition of STAT's Health Tech newsletter: Nuance's mysterious pric...
A study of thousands of people who were prescribed GLP-based drugs like Ozempic ...
U.S. births were flat last year, as the nation saw fewer babies born than it did...
Despite pressure from Congress and advocates, CMS isn’t changing its coverage pl...
Coherus BioSciences plans to sell a Humira biosimilar at a steep discount and wi...
Tempus, a company that combines DNA sequencing for cancer with artificial intell...
In a bold move, Coherus BioSciences plans to sell a Humira biosimilar at a steep...
Researchers and health care advocates are warning that the debt ceiling deal wou...
Republicans are selling a provision of the debt ceiling deal as a way to limit h...
Now is the time for advocates to demand the DEA enshrine telehealth care.
President Biden plans to tap longtime federal and state health official Mandy Co...
Despite pressure from Congress and advocates, Medicare is not changing its cover...
Kisqali, a breast cancer pill made by Novartis, reduced the risk of recurrence o...
